Skip to main content

Gould Robert J

In the past year, 3 open-market sale filings worth $489.3K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$489.3K
3 filings
Net
−$489.3K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Gould Robert J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

FULC Fulcrum Therapeutics, Inc.

Director8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 5, 2022 (view filing)Apr 1-54 daysGould Robert JDirectorSSale−94.3K$24.16−$2.28M−15.7%506.6K after3 lots
Apr 11, 2022 (view filing)Apr 74 daysGould Robert JDirectorSSale−5.63K$24.02−$135.3K−1.1%506.6K after
Jun 6, 2022 (view filing)Jun 2-64 daysGould Robert JDirectorSSale−66.6K$8.00−$532.8K−11.6%506.6K after3 lots
Jun 8, 2022 (view filing)Jun 71 dayGould Robert JDirectorSSale−71.4K$8.09−$577.9K−12.4%506.6K after
Jan 13, 2023 (view filing)Jan 13Same dayGould Robert JInterim President & CEOSSale−6.77K$15.00−$101.5K−1.3%499.9K after
Nov 21, 2025 (view filing)Nov 192 daysGould Robert JDirectorSSale−15.0K$11.03−$165.4K−3.0%484.9K after
Feb 4, 2026 (view filing)Feb 22 daysGould Robert JDirectorSSale−15.0K$10.72−$160.8K−3.2%454.9K after
Feb 4, 2026 (view filing)Jan 233 daysGould Robert JDirectorSSale−15.0K$10.87−$163.1K−3.1%469.9K afterAmended